MedCity News April 24, 2024
Game-changing advances can be achieved by integrating patient collaboration and priorities into the full span of trial design.
Clinical trials represent a critical path to innovative treatments, life-changing cures, and medical progress. But for all their scientific rigor, most trials fail to include one crucial element: input from the very people they aim to help.
In the past, patients have had little say in how clinical trials are designed. The responsibility of trial design is usually left to academics, clinicians, statisticians, and industry experts. However, a recent study by the Health Stories Project found that 97% of patients believe it is important for biopharmaceutical companies to include patient feedback when designing clinical trials. Additionally, 83% of patients expressed interest in...